Leaflet PENTHROX 99.9% 3ml LIQUID INHALATION VAPOR liquid for inhalation vapour


Indicated for: moderate to severe pain

Route of administration: inhalation

Substance: methoxyflurane (analgesic and antipyretic)

ATC: N02BG09 (Nervous system | Other analgesics and antipyretics)

Methoxyflurane is an inhaled anesthetic primarily used for the relief of acute pain of moderate to severe intensity. It is commonly employed in emergency situations, such as accidents, due to its rapid and effective action.

It is administered through a portable device that allows the patient to inhale the required dose, providing personalized pain control. It is important to note that its use is limited to low doses, as high doses can cause renal toxicity.

Methoxyflurane is contraindicated in patients with severe renal or hepatic impairment, as well as those with a history of hypersensitivity to this medication. It is also not recommended for long-term use.

This medication is considered safe and effective when used as directed, but it must be administered under the supervision of a qualified healthcare professional.

General data about PENTHROX 99.9% 3ml LIQUID INHALATION VAPOR

  • Substance: methoxyflurane
  • Date of last drug list: 01-09-2021
  • Commercial code: W67773001
  • Concentration: 99.9%
  • Pharmaceutical form: liquid for inhalation vapour
  • Packing volume: 3ml
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: MUNDIPHARMA DC B.V. - OLANDA
  • Holder: MEDICAL DEVELOPMENTS NED B.V. - OLANDA
  • Number: 10710/2018/01
  • Shelf life: 3 years